Research Partnership appoints new CEO
January 9, 2023 |
Research Partnership has appointed Gareth Phillips to take over as CEO
Research Partnership has appointed Gareth Phillips to take over as CEO, effective 9th January 2023. The two co-founding Directors, Mary Assimakopoulos and Mark Jeffery, are taking a step back from the operational running of the business, although they will remain on the Senior Management Team in an advisory capacity.
Research Partnership was acquired by Inizio last year and sits within the Advisory business unit. Inizio is a strategic partner for health and life sciences that unites a full suite of advisory, medical, marketing, communications, and patient and stakeholder engagement services.
Gareth was previously UK Managing Director and Head of EMEA for Ipsos, one of the world’s leading market research companies. He brings with him a wealth of global experience, having spent 25 years in healthcare market research working with IMS Health (now IQVIA) and Synovate Healthcare before it was acquired by Ipsos. At Synovate, he held roles based in the US, UK and Asia, and was the company’s Managing Director of Asia Pacific at the time of integration into Ipsos. Whilst at Ipsos, he spearheaded a transformation of the healthcare business in Europe, leading them to achieve consistent high growth over the past decade, and growing the team in London to more than 250 people.
Commenting on his appointment, Gareth said, “I am delighted and honoured to be taking on the role as CEO. I have long admired Research Partnership as a leader in the global healthcare market research space and look forward to building on the incredible success that Mark and Mary have achieved in the last 25 years.”
Previous co-Founding Director Mark Jeffery adds, “Gareth is a highly regarded figure in healthcare market research, and with him, we know that the company is in safe hands. We are confident that he will continue the strong growth that the company has enjoyed since its inception in 1997. We wish him every success.”
Gareth will report to Colin Stanley, President of Inizio Advisory.
To find out more about Research Partnership, visit www.researchpartnership.com
To find out more about Inizio and Inizio Advisory, please visit: www.inizio.health
This content was provided by Research Partnership
Company Details
Latest Content from Research Partnership
Kathy O’Connell joins Research Partnership as Senior Vice President, Business Development
Kathy has been working in the pharmaceutical market research industry for over 25 years. She has a diverse business background, with in-depth experience in progressively responsible sales, business development and...
Infographic: Therapy Watch Acute Myeloid Leukemia market snapshot
This Acute Myeloid Leukemia infographic offers a snapshot of the real-world patient insights collected by our Therapy Watch study, based on data collected from a panel of 220 physicians across...
Navigating the future of AI: Insights from EphMRA’s one day meeting in London
Authored by: Ellie Forde and Mark Braund, Directors
Research conducted for Johnson and Johnson published in scientific journal
Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.
Connecting our Inizio Advisory capabilities to help a client address a threat to the brand, guide strategy and improve brand performance
The challenge Our client knew that prescribing of a key brand in a major market had slowed and needed to understand which patient segments were impacted so they could address...
Autoimmune conditions: Living With syndicated patient reports
The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective management and care. In our...
How we elevated HCP market research engagement and insights using AI avatars for an immersive experience
Our client required an effective strategy for promoting discussions about self-paid vaccines with healthcare professionals (HCPs) during patient consultations. The conventional method of conducting market research would typically only deliver...
How we provided comprehensive real-world patient data for PAH using Therapy Watch, our syndicated market tracking solution
PAH is a specific type of pulmonary hypertension, which is a rare condition treated primarily in specialized centers. Our client needed to gain a comprehensive understanding of PAH patients, such...
The risk of replicating social bias in synthetic patient data – The need for human intelligence partnered with AI
Authored by Paul Reed and Anabelle Gall
Latest European developments and new talent at Research Partnership
Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its...